News - South America, Cardio-vascular


Popular Filters

Brazilian acute coronary syndrome drug market set to nearly double to $229 million in 2015


The acute coronary syndrome (ACS) drug market in Brazil will nearly double from $122 million in 2010…

AstraZenecaBrilintaCardio-vascularEffientEli LillyMarkets & MarketingPharmaceuticalSouth America

Daiichi Sankyo and Ranbaxy expand business in Mexico with launch of olmesartan


Japanese drug major Daiichi Sankyo (TYO: 4568) and its 64% owned Indian affiliate Ranbaxy Laboratories…

Cardio-vascularDaiichi SankyoGenericsMarkets & MarketingolmesartanRanbaxy LaboratoriesSouth America

Back to top